One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial.
Gough, S. C. L. 1; Bode, B. W. 2; Woo, V. C. 3; Rodbard, H. W. 4; Linjawi, S. 5; Zacho, M. 6; Reiter, P. D. 6; Buse, J. B. 7
Diabetes, Obesity & Metabolism.
17(10):965-973, October 2015.
(Format: HTML, PDF)